Cargando…

Nonsurgical Treatment for Localized Hepatocellular Carcinoma

The most common non-surgical approaches for the treatment of localized hepatocellular carcinoma remain hepatic artery-delivered particles laden with chemotherapy (TACE), or radioactive microparticles (TARE). External beam radiotherapy has been an effective option in many parts of the world for selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Andrew S., Sangro, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921451/
https://www.ncbi.nlm.nih.gov/pubmed/24488546
http://dx.doi.org/10.1007/s11912-013-0373-x
_version_ 1782303304039006208
author Kennedy, Andrew S.
Sangro, Bruno
author_facet Kennedy, Andrew S.
Sangro, Bruno
author_sort Kennedy, Andrew S.
collection PubMed
description The most common non-surgical approaches for the treatment of localized hepatocellular carcinoma remain hepatic artery-delivered particles laden with chemotherapy (TACE), or radioactive microparticles (TARE). External beam radiotherapy has been an effective option in many parts of the world for selected HCC patients, but now has an expanded role with stereotactic and proton beam technologies. This review focuses on existing evidence and current guidance for utilizing these modalities for localized, but unresectable, non-transplantable HCC patients.x
format Online
Article
Text
id pubmed-3921451
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-39214512014-02-19 Nonsurgical Treatment for Localized Hepatocellular Carcinoma Kennedy, Andrew S. Sangro, Bruno Curr Oncol Rep Gastrointestinal Cancers (B Czito, Section Editor) The most common non-surgical approaches for the treatment of localized hepatocellular carcinoma remain hepatic artery-delivered particles laden with chemotherapy (TACE), or radioactive microparticles (TARE). External beam radiotherapy has been an effective option in many parts of the world for selected HCC patients, but now has an expanded role with stereotactic and proton beam technologies. This review focuses on existing evidence and current guidance for utilizing these modalities for localized, but unresectable, non-transplantable HCC patients.x Springer US 2014-02-02 2014 /pmc/articles/PMC3921451/ /pubmed/24488546 http://dx.doi.org/10.1007/s11912-013-0373-x Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Gastrointestinal Cancers (B Czito, Section Editor)
Kennedy, Andrew S.
Sangro, Bruno
Nonsurgical Treatment for Localized Hepatocellular Carcinoma
title Nonsurgical Treatment for Localized Hepatocellular Carcinoma
title_full Nonsurgical Treatment for Localized Hepatocellular Carcinoma
title_fullStr Nonsurgical Treatment for Localized Hepatocellular Carcinoma
title_full_unstemmed Nonsurgical Treatment for Localized Hepatocellular Carcinoma
title_short Nonsurgical Treatment for Localized Hepatocellular Carcinoma
title_sort nonsurgical treatment for localized hepatocellular carcinoma
topic Gastrointestinal Cancers (B Czito, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921451/
https://www.ncbi.nlm.nih.gov/pubmed/24488546
http://dx.doi.org/10.1007/s11912-013-0373-x
work_keys_str_mv AT kennedyandrews nonsurgicaltreatmentforlocalizedhepatocellularcarcinoma
AT sangrobruno nonsurgicaltreatmentforlocalizedhepatocellularcarcinoma